Method of treating colon, renal, and lung carcinomas with .gamma.-interferon and Ser.sup.71 !-interleukin-1.beta.
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsKazuyoshi Kawai, Yasue Konishi, Satoru Nakai, Yoshikatsu Hirai
Life of this patent
Estimating the term…
Abstract
This invention provides an anti-tumor agent and a method for treating a tumor wherein gamma-interferon and interleukin-1 are used as active ingredients.
Claims2
A method of inhibiting tumor growth which consists essentially of administering an anti-tumor effective amount of naturally occurring gamma-interferon and Ser.sup.71 !interleukin-1.beta. to a tumor-bearing patient, wherein the tumor is selected from the group consisting of colon adenocarcinoma, renal cancer and lung adenocarcinoma.
The method of inhibiting tumor growth which consists essentially of administering an anti-tumor effective amount of naturally occurring gamma-interferon and Ser.sup.71 !interleukin-1.beta. to a tumor-bearing patient, wherein said anti-tumor effective amount of naturally occurring gamma-interferon is from about 4.2 .mu.g/body/day to 4.2 mg/body/day and said anti-tumor effective amount of Ser.sup.71 !interleukin-1.beta. is from about 0.08 to 8 .mu.g/body/day, and wherein the tumor is selected from the group consisting of colon adenocarcinoma, renal cancer and lung adenocarcinoma.
Dependencies are inferred from the claim text.